ExoAim Technology
Home > Our Technology > ExoAim Technology
Turquoise Biotechnologies
ExoAim Technology
ExoAim is a pioneering biotechnology that leverages the natural properties of exosomes to create highly targeted therapeutic agents. Exosomes are small extracellular vesicles secreted by cells, playing a crucial role in intercellular communication. Our innovative approach involves modifying parent cells to produce exosomes that are engineered with specific binding domains on their membranes. This customization enhances their ability to selectively target and engage with particular cells and organs in the body.


Turquoise Biotechnologies
Mechanism of Action
Cell Modification
By utilizing advanced genetic engineering techniques, we alter the parent cells to express unique binding domains on the surface of the exosomes they release. These domains are designed to recognize and bind to receptor proteins that are predominantly found on the target cells.
Targeting Precision
Once released into the bloodstream or other biological environments, the modified exosomes can efficiently navigate to their intended target. The binding domains facilitate adherence to the specific receptors present on the cytoplasmic membranes of the target cells, ensuring precise delivery.
Internalization
After binding, the exosomes are internalized by the target cells through endocytosis. This process allows for the direct transfer of therapeutic payloads—such as RNA, proteins, or small molecules—into the cells, maximizing efficacy while minimizing off-target effects.